| Literature DB >> 35117673 |
Giselle Diniz Guimarães da Silva1, Tiago Novaes Pinheiro2.
Abstract
BACKGROUND: Oral leukoplakia is the most common potentially malignant lesion, the etiology of this change is still uncertain which makes it difficult to predict when this will undergo malignant transformation. Recent studies have examined the involvement of mast cells in this process, it is believed that these cells through the release of pro-angiogenic factors influence the processing mechanism of such lesions through promoting angiogenesis. It was the objective of this study to evaluate the inflammatory process in oral leukoplakia comparing it to a non-cancerous lesion correlating the intensity of mast cells with inflammatory infiltrate and vascularization in these lesions.Entities:
Keywords: Inflammation; leukoplakia; mast cells; vascularization
Year: 2020 PMID: 35117673 PMCID: PMC8797343 DOI: 10.21037/tcr.2019.12.23
Source DB: PubMed Journal: Transl Cancer Res ISSN: 2218-676X Impact factor: 1.241
Figure 1Inflammatory infiltrate count representation for qualitative classification in an inflammatory fibrous hyperplasia case. HE stain (magnification 400×).
Figure 2Blood vessels count representation in an oral leucoplakia case. HE stain (magnification 400×).
Figure 3Toluidine blue stain photomicrograph marking mast cells in the connective tissue (magnification 400×).
Figure 4Graph 1: evaluation of the inflammatory infiltrate intensity in oral leukoplakia (Group 1) and in inflammatory fibrous hyperplasia (Group 2).
The table compares the clinical features observed in group 1 (oral leukoplakia) and group 2 (inflammatory fibrous hyperplasia)
| Group | Age in years | Average age | Gender | Location |
|---|---|---|---|---|
| 1 | 33–69 | 51 | Males (70%) | Buccal mucosa (60%); tongue (20%); lower lip mucosa (20%) |
| 2 | 14–65 | 50 | Females (90%) | Buccal mucosa (80%); tongue (10%); lip (10%) |
Comparison of the average mast cells and blood vessels in oral leukoplakia and inflammatory fibrous hyperplasia. Group 1 (oral leukoplakia), Group 2 (IFH); P (statistical significance)
| Variables | Group 1 | Group 2 | F | ANOVA |
|---|---|---|---|---|
| Mast cells | 2.67 | P<0.06 | ||
| Mean | 3.48 | 3.99 | ||
| SD | 2.75 | 2.68 | ||
| Blood vessels | 2.67 | |||
| Mean | 1.83 | 1.65 | ||
| SD | 1.74 | 1.69 |
The table shows the cases of oral leukoplakia represented according to the presence and grade of dysplasia
| Case | Dysplasia presence | Dysplasia grade | |
|---|---|---|---|
| Yes | No | ||
| I | X | ||
| II | X | ||
| III | X | Moderate | |
| IV | X | Moderate | |
| V | X | Mild | |
| VI | X | Mild | |
| VII | X | Mild | |
| VIII | X | Moderate | |
| IX | X | Mild | |
| X | X | Mild | |
The table shows the means of mast cells and blood vessels per field in the different grades of dysplasia of oral leukoplakia
| Case | Mean per field | Dysplasia grade | |
|---|---|---|---|
| Mast cell | Blood vessels | ||
| I | 2.6 | 1.5 | – |
| II | 4.0 | 0.9 | – |
| III | 4.7 | 0.8 | Moderate |
| IV | 1.6 | 0.5 | Moderate |
| V | 2.5 | 1.1 | Mild |
| VI | 4.9 | 3.0 | Mild |
| VII | 2.8 | 3.2 | Mild |
| VIII | 3.9 | 1.9 | Moderate |
| IX | 3.6 | 2.1 | Mild |
| X | 4.2 | 3.3 | Mild |
The table shows the means of mast cells and blood vessels per field in the IFH lesions
| Case | Mean per field | |
|---|---|---|
| Mast cell | Blood vessels | |
| I | 3.5 | 0.9 |
| II | 6.3 | 0.7 |
| III | 5.9 | 1.6 |
| IV | 4.2 | 2.8 |
| V | 5.3 | 2.9 |
| VI | 2.7 | 1.3 |
| VII | 5.5 | 0.4 |
| VIII | 1.6 | 0.7 |
| IX | 1.8 | 4.3 |
| X | 2.8 | 0.9 |